A Health Economic Analysis for Oral Poliovirus Vaccine to Prevent COVID‐19 in the United States

Lignende værker

• No Role for Reintroducing OPV into the United States with Respect to Controlling COVID‐19 [Response to the letter to the Editor by Chumakov et al.]
  af: Thompson, Kimberly M., et al.
  Udgivet: (2021)
• Logistical challenges and assumptions for modeling the failure of global cessation of oral poliovirus vaccine (OPV)
  af: Thompson, Kimberly M., et al.
  Udgivet: (2019)
• Expected implications of globally-coordinated cessation of serotype 3 oral poliovirus vaccine (OPV) before serotype 1 OPV
  af: Kalkowska, Dominika A., et al.
  Udgivet: (2020)
• Potential Future Use, Costs, and Value of Poliovirus Vaccines
  af: Thompson, Kimberly M., et al.
  Udgivet: (2020)
• Health and economic outcomes associated with polio vaccine policy options: 2019–2029
  af: Kalkowska, Dominika A., et al.
  Udgivet: (2021)